The Yonglin Healthcare Foundation is to partner with BioNTech to develop mRNA-based cancer immunotherapies, said Terry Gou (郭台銘), founder of the foundation and manufacturing giant Hon Hai Precision Industry.
BioNTech is also planning to set up a clinical trial hub in Taiwan for mRNA-based cancer immunotherapies as part of its Asia-Pacific expansion, Gou wrote on Facebook on Friday.
The German biotech firm, which developed a widely used mRNA COVID-19 vaccine, said in a separate statement that it would collaborate with Yonglin after signing a memorandum of understanding with Retain Biotech Corp.
Photo: CNA
Retain Biotech, a Taiwan-based company sponsored by the foundation, is engaged in precision and genomic medicine and cell therapy for treating cancers, BioNTech said.
Gou said the German company has set up an office in Taiwan to perform an initial assessment of its cancer product candidate, BNT113, which is targeted at treating head and neck cancers.
Taiwan is expected to participate in BioNTech’s mRNA-based cancer immunotherapy development, he said.
BioNTech said that BNT113 is expected to be the first of several novel cancer immunotherapies that it anticipates assessing in the region.
Under the memorandum of understanding, Retain is expected to support the clinical evaluation of BNT113 in a randomized phase two clinical trial across the region, BioNTech said.
“BioNTech’s mRNA technology has not only saved the world from the COVID-19 pandemic, but also raised hopes that the technology will help medical circles take a leap in cancer treatment,” Gou said.
“That has been the intention of BioNTech founder and CEO Ugur Sahin, and it is the first time that he believes his wish to beat cancer could come true,” he said.
At Gou’s invitation, BioNTech executives in January visited the National Taiwan University Cancer Center to better understand Taiwan’s cancer treatment environment, its medical equipment and achievements in the biotech field.
While in Taiwan, the executives evaluated Taiwan’s needs in the hopes of creating a blueprint for treating cancer in the country, Gou said.
In July, he led a delegation to BioNTech’s headquarters in Germany to brief Sabin on Taiwan’s plans to work with the company on head and neck cancer, breast cancer and leukemia.
In the Facebook post, Gou praised the partnership, saying that Taiwan could not afford to be left behind in the battle against cancer.
BioNTech chief business officer Sean Marett said his company’s goal with the Retain agreement was to accelerate the development of innovative therapies to help address cancers, which have been highly prevalent in the region.
BioNTech said it planned to evaluate BNT113 in the broader Asia-Pacific region starting with clinical trials in Taiwan and in Australia’s Victoria state.
It will also assess the expansion of clinical activities to Japan, South Korea, Singapore and other economies in the region for cancer-related therapies, which already encompasses 18 product candidates in 23 ongoing clinical trials.
A magnitude 4.9 earthquake struck off Tainan at 11:47am today, the Central Weather Administration (CWA) said. The hypocenter was 32.3km northeast of Tainan City Hall at a depth of 7.3km, CWA data showed. The intensity of the quake, which gauges the actual effect of a seismic event, measured 4 in Tainan and Chiayi County on Taiwan's seven-tier intensity scale, the data showed. The quake had an intensity of 3 in Chiayi City and County, and Yunlin County, while it was measured as 2 in Kaohsiung, Nantou County, Changhua County, Taitung County and offshore Penghu County, the data showed. There were no immediate reports of
Weather conditions across Taiwan are expected to remain stable today, but cloudy to rainy skies are expected from tomorrow onward due to increasing moisture in the atmosphere, according to the Central Weather Administration (CWA). Daytime highs today are expected to hit 25-27°C in western Taiwan and 22-24°C in the eastern counties of Yilan, Hualien, and Taitung, data on the CWA website indicated. After sunset, temperatures could drop to 16-17°C in most parts of Taiwan. For tomorrow, precipitation is likely in northern Taiwan as a cloud system moves in from China. Daytime temperatures are expected to hover around 25°C, the CWA said. Starting Monday, areas
Taiwan has recorded its first fatal case of Coxsackie B5 enterovirus in 10 years after a one-year-old boy from southern Taiwan died from complications early last month, the Centers for Disease Control (CDC) said yesterday. CDC spokesman Lo Yi-chun (羅一鈞) told a news conference that the child initially developed a fever and respiratory symptoms before experiencing seizures and loss of consciousness. The boy was diagnosed with acute encephalitis and admitted to intensive care, but his condition deteriorated rapidly, and he passed away on the sixth day of illness, Lo said. This also marks Taiwan’s third enterovirus-related death this year and the first severe
A Taiwanese software developer has created a generative artificial intelligence (AI) model to help people use AI without exposing sensitive data, project head Huang Chung-hsiao (黃崇校) said yesterday. Huang, a 55-year-old coder leading a US-based team, said that concerns over data privacy and security in popular generative AIs such as ChatGPT and DeepSeek motivated him to develop a personal AI assistant named “Mei.” One of the biggest security flaws with cloud-based algorithms is that users are required to hand over personal information to access the service, giving developers the opportunity to mine user data, he said. For this reason, many government agencies and
RSS